More Evidence for Buffered Anesthetic
New research shows that buffered articaine can significantly reduce injection pain and speed the onset of anesthesia compared to nonbuffered formulations. See why buffered...
- A randomized clinical trial found that buffered articaine produced significantly less injection pain, eliminated burning sensations, and achieved pulpal anesthesia twice as fast as nonbuffered articaine.
- Buffering local anesthetics with sodium bicarbonate raises the pH, increasing the amount of active anesthetic available and reducing the discomfort associated with acidic injections.
- Faster, more comfortable anesthesia can improve patient experience, practice efficiency, and patient perception of care, making buffered anesthetics an increasingly attractive option for dental practices.
Buffered Anesthetic: The New Standard of Care
Buffered local anesthesia cuts injection pain and acts faster. With new affordable technology, dentists can enhance patient comfort while meeting legal responsibilities, setting a new standard of care...
- Buffered anesthetic improves the patient experience. By neutralizing the acidity of traditional anesthetics, buffering reduces injection pain, speeds onset, and can improve anesthetic success.
- A new standard of care is emerging. With modern systems making buffering simple, fast, and affordable, practices can now deliver more comfortable and efficient anesthesia.
- Informed consent now includes anesthetic options. Dentists have a legal and ethical responsibility to disclose buffered versus nonbuffered anesthesia so patients can participate in decisions about their care.
Buffered Anesthesia Rivalry Heats up in Dental Industry
When 58% of patients say the injection is the worst part of the dental experience, it's time someone did something about it, and that's exactly what is happening right now...
“Buffering improves patient comfort, enhances time management, decreases doses, and improves safety and efficacy. Ultimately, it leads to more efficient and pleasant dental experiences.”
“In view of these new products, a threshold has been crossed, and in 2025, buffering should be the standard of care. I wouldn’t give an unbuffered anesthetic to my family or my patients, and no informed patient would consent to an unbuffered injection,” DiMarco told Dr. Bicuspid.
Septodont Invests in Balanced Pharma, Joins Board
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional funding round
Septodont, the dominant global leader in dental anesthetics, has made a strategic investment in Balanced Pharma Inc. (“BPI”) as part of an institutional funding round, and Septodont COO Atif Zia has joined the BPI Board of Diretors…
Balanced Pharma Analgesic Aims to Lower Opioid Use
Balanced Pharma has announced the acquisition of rights to a promising new non-opioid injectable post-surgical pain relief drug, Enduracaine Dental, for the worldwide dental market
As the nation continues to grapple with the ongoing opioid epidemic, Balanced Pharma believes adding Enduracaine Dental to its development pipeline will expand its offering of improved pain management tools for dental professionals, and hopes to significantly reduce the number of opioid prescriptions…
Dr. Howard S. Glazer Joins Balanced Pharma
Leading dental educator predicts huge impact for patients, providers
Howard S. Glazer, DDS, FAGD has joined Balanced Pharma’s Scientific Advisory Board. Dr. Glazer, an award-winning, leading voice in dental education, joins the dentist-founded pharmaceutical startup Balanced Pharma as they progress toward commercialization of BPI-001 and BPI-002, their first pipeline drugs in development. Dr. Glazer and other key opinion leaders believe BPI-001 and BPI-002 are likely to be “game-changers” in the billion-dollar-plus injectable dental anesthetic category…
Revolutionizing Dental Injections: The Balanced Pharma Story
Innovation to improve patient comfort and treatment efficiency is poised to make waves in the industry in the near future
In the world of dentistry, innovations that improve patient comfort and treatment efficiency are always welcome. One such innovation is poised to make waves in the industry in the near future. Dr. Scott Keadle, the founder and CEO of Balanced Pharma, recently shared insights about a groundbreaking dental anesthetics innovation…
Balanced Pharma Expands Patent Portfolio for Less Painful Dental Anesthetic
Dentist-founded company receives additional U.S. patent for its dental cartridge technology
Balanced Pharma has received notification from the United States Patent & Trademark Office on the issuance of an additional U.S. patent for the dentist-founded company’s proprietary cartridge technology. This patent enhances the…
Balanced Pharma Announces First 75 Members of Its Clinical Advisory Board
The Board includes practicing clinicians across multiple specialties that use local anesthetic, including dentistry, dermatology, interventional radiology, plastic surgery, and emergency medicine
“We are proud to welcome these talented and successful dentists, clinicians, and thought leaders from numerous medical specialties who share Balanced Pharma’s commitment to advancing patient comfort,” says Jason Suggs, Chief Communications Officer. “We look forward to engaging with this incredible group of individuals and to growing our Clinical Advisory Board, as we work together to bring…
New Patent: Less Pain, Less Wait at Dentist Office?
Balanced Pharma Expands Patent Portfolio, Fills Need for Less Painful, Fast-Acting, More Reliable Dental Injections
The United States Patent & Trademark Office has granted Balanced Pharma, Inc. (BPI) a second patent for its cartridge technology, which enables the long-sought ability to deliver acid-free local anesthetics in a standard dental cartridge…
Balanced Pharma's Acid-Free Anesthetic Cartridge Gets Patent
New drug candidate is a local anesthetic intended specifically for the dental market and will be supplied in a standard dental cartridge
The U.S. Patent and Trademark Office has granted Balanced Pharma a second patent for its cartridge technology that allows for the delivery of acid-free local anesthetics for dentistry…
Alex Sadusky Joins Balanced Pharma Incorporated's Advisory Board
TruBlu Co-Founder & CEO and Veteran Dental Industry Executive Joins BPI's Mission to Make Less Painful, Faster-Acting Dental Injections a Reality
“When I met the Balanced Pharma Team and learned about their mission to make dental injections less painful, faster-acting, and more reliable, I knew I wanted to be a part of making that happen,” says Sadusky…
Most Patients Would Pay More for Less Painful Anesthetic Procedures
The Majority of Dental Patients Want a Faster, Less Painful Local Anesthetic
“The survey responses were a wonderful reminder of just how much people care about others,” said Dr. Scott Keadle. “Clearly, people want dental injections to be less painful, but they really want their loved ones to have less painful injections…”
